Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-50045.14%
operating margin TTM
-28675.78%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.12 |
| peg ratio | 0.00 |
| price to book ratio | -0.00 |
| price to sales ratio | 42.55 |
| enterprise value multiple | 0.32 |
| price fair value | -0.00 |
profitability ratios | |
|---|---|
| gross profit margin | -588.66% |
| operating profit margin | -28675.78% |
| pretax profit margin | -50800.12% |
| net profit margin | -50045.14% |
| return on assets | -563.97% |
| return on equity | 0.0% |
| return on capital employed | 191.25% |
liquidity ratios | |
|---|---|
| current ratio | 0.35 |
| quick ratio | 0.35 |
| cash ratio | 0.18 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 203.53 |
| days of payables outstanding | 1,887.27 |
| cash conversion cycle | -1,683.74 |
| receivables turnover | 1.79 |
| payables turnover | 0.19 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 2.02 |
| debt equity ratio | -0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | -0.00 |
| interest coverage | -177.52 |
| cash flow to debt ratio | -404,930.64 |
cash flow ratios | |
|---|---|
| free cash flow per share | -248,138.06 |
| cash per share | 0.14 |
| operating cash flow per share | -248,138.06 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -404,930.64 |
| short term coverage ratios | -407,505.51 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Outlook Therapeutics, Inc. (NASDAQ:OTLK) reported earnings?
Outlook Therapeutics, Inc. (OTLK) published its most recent earnings results on 17-02-2026.
What is Outlook Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Outlook Therapeutics, Inc. (NASDAQ:OTLK)'s trailing twelve months ROE is 0.0%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Outlook Therapeutics, Inc. (OTLK) currently has a ROA of -563.97%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did OTLK's net profit margin stand at?
OTLK reported a profit margin of -50045.14% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is OTLK's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.35 in the most recent quarter. The quick ratio stood at 0.35, with a Debt/Eq ratio of -0.00.